We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bayer Invests in GRO Biosciences’ Pioneering Protein Therapeutics Efforts
Bayer Invests in GRO Biosciences’ Pioneering Protein Therapeutics Efforts
Bayer is investing in GRO Biosciences, a Boston-based company that is developing protein therapeutics for patients with autoimmune and metabolic diseases.